Bioresorbable drug-eluting scaffolds for treatment of vascular disease.

about

Bioresorbable drug-eluting scaffolds for treatment of vascular disease.

Item

http://www.wikidata.org/entity/Q38728978

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bioresorbable drug-eluting scaffolds for treatment of vascular disease.

@en

type

Item

label

Bioresorbable drug-eluting scaffolds for treatment of vascular disease.

@en

prefLabel

Bioresorbable drug-eluting scaffolds for treatment of vascular disease.

@en

P1476

Bioresorbable drug-eluting scaffolds for treatment of vascular disease.

@en

P2093

Erhan Tenekecioglu

http://www.w3.org/2001/XMLSchema#string

Hiroki Tateishi

http://www.w3.org/2001/XMLSchema#string

Joanna J Wykrzykowska

http://www.w3.org/2001/XMLSchema#string

Pannipa Suwannasom

http://www.w3.org/2001/XMLSchema#string

Robbert J De Winter

http://www.w3.org/2001/XMLSchema#string

Robin P Kraak

http://www.w3.org/2001/XMLSchema#string

Yaping Zeng

http://www.w3.org/2001/XMLSchema#string

Yohei Sotomi

http://www.w3.org/2001/XMLSchema#string

Yoshinobu Onuma

http://www.w3.org/2001/XMLSchema#string

P2860

Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?

Bioresorbable scaffolds: rationale, current status, challenges, and future.

TOR, a central controller of cell growth.

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients

P304

725-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2016.1153062

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrick W Serruys

P577

2016-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26865247

http://www.w3.org/2001/XMLSchema#string